Stéphane Richard

17PUBLICATIONS
42CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Tissue engineeringMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 18, 2024
A group 3 medulloblastoma stem cell program is maintained by OTX2-mediated alternative splicing.

Olivier Saulnier, Jamie Zagozewski, Lisa Liang

|Jun 13, 2023
Protein arginine methyltransferase 1 regulates B cell fate after positive selection in the germinal center in mice.

Ludivine C Litzler, Astrid Zahn, Kiersten L Dionne

|Jun 07, 2023
Inhibition of type I PRMTs reforms muscle stem cell identity enhancing their therapeutic capacity.

Claudia Dominici, Oscar D Villarreal, Junio Dort

|Jun 15, 2022
PRMT1 is required for the generation of MHC-associated microglia and remyelination in the central nervous system.

Jeesan Lee, Oscar David Villarreal, Yu Chang Wang

|May 23, 2022
The Influence of Arginine Methylation in Immunity and Inflammation.

Nivine Srour, Sarah Khan, Stephane Richard

Pageof 3